Ancer Saliva Test News Today

Early data suggest that several new multicancer early detection tests can identify a range of cancers that lack routine screening options.

A blood test to screen for ovarian cancer is one of many new liquid biopsy assays being evaluated to screen for cancer.

A new screening test raises the possibility of catching pancreatic cancer earlier, when tumors can be removed, and patients cured.

Blood-based screening for CRC may be better than no screening at all, but it can't replace colonoscopy as the gold standard, according to two new modeling studies and an expert consensus commentary.

In unscreened adults who refuse colonoscopy, liquid biopsy tests may not have sufficient performance and cost too much to be a viable strategy at this time, an economic analysis suggests.

Grail announced a step that may help move the company closer to securing Medicare reimbursement for its Galleri multicancer blood test, sold in the US since 2021.

Scientists in Spain have detected circulating tumor DNA in breast milk even before it appeared in blood.

Marcy Duncan hadnt fully healed from her surgery for stage I breast cancer. She expected to discuss radiation and other next treatment steps. But her doctor raised a more serious concern.

Measuring ctDNA levels before radiotherapy predicted PFS and overall survival, and can help determine the patients most likely to benefit from consolidation radiotherapy vs systemic therapy.

The CEO of Moderna speaks with WebMD CMO John Whyte, MD, MPH, about the potential of mRNA technology and much more.